Article
Spectrum of mutations in CRM-positive and CRM-reduced hemophilia A.
Genomics - 1 Feb 1993
McGinniss M J, Kazazian H H, Hoyer L W, Bi L, Inaba H, Antonarakis S E
Abstract excerpt
Hemophilia A is due to the functional deficiency of factor VII (FVIII, gene locus F8C). Although half the patients have no detectable FVIII protein in their plasma, the more rare patients (approximately 5%) have normal levels of a dysfunctional FVIII and are termed cross-reacting material (CRM)-positive. More commonly (approximately 45%), patients have plasma FVIII protein reduced to an extent roughly comparable...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
